KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Invested Capital (2023 - 2025)

Aquestive Therapeutics (AQST) has 3 years of Return on Invested Capital data on record, last reported at 1.08% in Q1 2025.

  • For Q1 2025, Return on Invested Capital rose 34.0% year-over-year to 1.08%; the TTM value through Mar 2025 reached 1.08%, up 34.0%, while the annual FY2024 figure was 0.8%, 56.0% up from the prior year.
  • Return on Invested Capital reached 1.08% in Q1 2025 per AQST's latest filing, down from 3.95% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 3.95% in Q4 2024 and bottomed at 4.65% in Q3 2024.
  • Average Return on Invested Capital over 3 years is 0.05%, with a median of 0.35% recorded in 2023.
  • The widest YoY moves for Return on Invested Capital: up 370bps in 2024, down -499bps in 2024.
  • A 3-year view of Return on Invested Capital shows it stood at 0.25% in 2023, then soared by 1489bps to 3.95% in 2024, then plummeted by -73bps to 1.08% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 1.08% in Q1 2025, 3.95% in Q4 2024, and 4.65% in Q3 2024.